3714-60-1
Chemical Structure
Ara-ATP
- CAS No.: 3714-60-1
- Formula:C10H16N5O13P3
- Molecular Weight:507.18
IUPAC Name: ((2R,3S,4S,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate
InChIKey: ZKHQWZAMYRWXGA-UHTZMRCNSA-N
SMILES: NC1=C2N=CN([C@@H]3O[C@H](COP(OP(OP(O)(O)=O)(O)=O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC=N1
Biological Activity: Ara-ATP is an ATP-competitive poly (A) polymerase (poly (A) polymerase) inhibitor with a Ki value of 4 μM for the chromatin-bound form and a Ki value of 60 μM for the nucleoplasmic (free) form. Ara-ATP blocks pre-mRNA 3' end processing by inhibiting endonucleolytic cleavage, poly (A) addition, and the formation of cleavage and polyadenylation-specific RNA-protein complexes. Ara-ATP selectively inhibits initial polyadenylation rather than poly (A) elongation. Ara-ATP is used in the study of viral infections[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ara-ATP | Ara-ATP is an ATP-competitive poly (A) polymerase (poly (A) polymerase) inhibitor with a Ki value of 4 μM for the chromatin-bound form and a Ki value of 60 μM for the nucleoplasmic (free) form. Ara-ATP blocks pre-mRNA 3' end processing by inhibiting endonucleolytic cleavage, poly (A) addition, and the formation of cleavage and polyadenylation-specific RNA-protein complexes. Ara-ATP selectively inhibits initial polyadenylation rather than poly (A) elongation. Ara-ATP is used in the study of viral infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Ghoshal K, et al. Ara-ATP impairs 3'-end processing of pre-mRNAs by inhibiting both cleavage and polyadenylation. Nucleic acids research. 1991 Nov 11;19(21):5871-5. [Content Brief]
- [2]. Rose KM, et al. Selective inhibition of RNA polyadenylation by Ara-ATP in vitro: a possible mechanism for antiviral action of Ara-A. Biochem Biophys Res Commun. 1978 Apr 28;81(4):1418-24.
